Diagnostic PCR in melanoma, methods and quality assurance. Epalinges, Switzerland, 26/27 January 1996

European Journal of Cancer Part A

Volumn 32, Issue 10, 1996, Pages 1661-1663

  Keilholz, U ^a  

^a UNIVERSITY OF HEIDELBERG   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

MONOPHENOL MONOOXYGENASE; TUMOR ANTIGEN;

DISSEMINATED CANCER; HUMAN; MELANOMA; PRIORITY JOURNAL; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; SHORT SURVEY;

EID: 0030249670     PISSN: 09598049     EISSN: None     Source Type: Journal    
DOI: 10.1016/0959-8049(96)00158-X     Document Type: Conference Paper

References (16)

1. 1. Smith B, Selby P, Southgate J, et al. Detection of melanoma cells in peripheral blood by means of reverse transcriptase and polymerase chain reaction. Lancet 1991, 338, 1227-1229.
2. 2. Brossart P, Keilholz U, Willhauck M, et al. Hematogenous spread of malignant melanoma cells in different stages of disease. J Invest Dermatol 1993, 101, 887-889.
3. 3. Tobal K, Sherman LS, Foss AJ, Lightman SL. Detection of melanocytes from uveal melanoma in peripheral blood using the polymerase chain reaction. Invest Ophthalmol Vis Sci 1993, 34, 2622-2625.
4. 4. Brossart P, Keilholz U, Scheibenbogen C, Möhler T, Willhauck M, Hunstein W. Detection of residual tumor cells in patients with malignant melanoma responding to immunotherapy. J Immunother 1994, 15, 38-41.
5. 5. Foss AJ, Guille MJ, Occleston NL, Hykin PG, Hungerford JL, Lightman S. The detection of melanoma cells in peripheral blood by reverse transcription-polymerase chain reaction. Br J Cancer 1995, 72, 155-159.
6. 6. Battayani Z, Grob J, Xerri L, et al. PCR detection of circulating melanocytes as a prognostic marker in patients with melanoma. Arch Dermatol 1995, 131, 443-447.
7. 7. Hoon DSB, Wang Y, Dale PS, et al. Detection of occult melanoma cells in blood with a multiple-marker polymerase chain reaction assay. J Clin Oncol 1995, 13, 2109-2116.
8. 8. Brossart P, Schmier J, Krüger S, et al. A PCR-based semiquantitative assessment of malignant melanoma cells in peripheral blood. Cancer Res 1995, 55, 4065-4068.
9. 9. Wang X, Heller R, VanVoorhis N, et al. Detection of submicroscopic lymph node metastases with polymerase chain reaction in patients with malignant melanoma. Ann Surg 1994, 220, 768-774.
10. 10. De Plaen E, Arden K, Traversari C, et al. Structure, chromosomal localization and expression of twelve genes of the MAGE family. Immunogenetics 1994, 40, 360-369.
11. 11. Coulie PG, Brichard V, van Pel A, et al. A new gene coding for a differentiation antigen recognized by autologous cytoloytic T lymphocytes on HLA-A2 melanomas. J Exp Med 1994, 180, 35-12.
12. 12. Kawakami Y, Eliyahu S, Delgado CH, et al. Cloning the gene coding for a shared human melanoma antigen recognized by autologous T cells infiltrating into tumor. Proc Natl Acad Sci USA 1994, 91, 3515-3519.
13. 13. Adema GJ, de Boer AJ, Vogel AM, Loenen WA, Figdor CG, Molecular characterization of the melanoma linage specific antigen gp 100. J Biol Chem 1994, 269, 20126-20133.
14. 14. Chomczynski P, Sacchi N. Single step method of RNA isolation by acid guanidinium thiocyanate-phenol-chloroform extraction. Analyt Biochem 1987, 162, 156.
15. 15. Gaugler B, van den Eynde B, van der Bruggen P, et al. Human gene MAGE-3 codes for an antigen recognized on a melanoma by autologous cytoloytic T lymphocytes. J Exp Med 1994, 179, 921-930.
16. 16. Brasseur F, Rimoldi D, Lienard D, et al. Expression of MAGE genes in primary and metastatic cutaneous melanoma. Int J Cancer 1995, 63, 375-380.